The topical pan-JAK Inhibitor Delgocitinib as a Cream shows a Dose Effect in a 16-week Phase IIb Study in Patients with chronic Hand Eczema (CHE)

M. Worm,J. Thyssen,S. Schliemann, A. Bauer,V Shi, B. Ehst, S. Tillmann, S. Korn, Resen K. Andersen,T. Agner

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT（2021）

Cited 0|Views2

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined